The estimated Net Worth of Aaron Mendelsohn is at least 572 千$ dollars as of 19 November 2014. Mr. Mendelsohn owns over 30,000 units of Vivani Medical Inc stock worth over 572,376$ and over the last 10 years he sold EYES stock worth over 0$. In addition, he makes 0$ as Independent Director at Vivani Medical Inc.
Sign up
Mr. Mendelsohn EYES stock SEC Form 4 insiders trading
Aaron has made over 1 trades of the Vivani Medical Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently he bought 30,000 units of EYES stock worth 270,000$ on 19 November 2014.
The largest trade he's ever made was buying 30,000 units of Vivani Medical Inc stock on 19 November 2014 worth over 270,000$. On average, Aaron trades about 4,286 units every 0 days since 2014. As of 19 November 2014 he still owns at least 138,255 units of Vivani Medical Inc stock.
You can see the complete history of Mr. Mendelsohn stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Aaron Mendelsohn biography
Aaron Mendelsohn serves as Independent Director of the Company. Mr. Mendelsohn is a founder and has served as a director of Second Sight since inception. Mr. Mendelsohn served on the board of Advanced Bionics since shortly after its founding in 1993 until its sale in 2004 to Boston Scientific Corp. Mr. Mendelsohn was also a founder and director of Medical Research Group from its inception in 1998 until its sale in 2001 to Medtronic, Inc. Mr. Mendelsohn previously served on the board of directors for the Alfred E. Mann Institute for Biomedical Engineering at the University of Southern California since its inception in 1998 until mid-2016. Mr. Mendelsohn is a founder and, since 2007, a director of Nanoprecision Holding Company, Inc., a company engaged in manipulating materials at nanometer scale. He is also a founder and director of Nanoprecision Medical, Inc., a drug delivery company working in nanotechnology, since its inception in 2011. Mr. Mendelsohn is a founder and serves as Chairman of the Maestro Foundation since it was organized in 1983. The Maestro Foundation is a leading non-profit musical philanthropic organization which hosts a premier chamber music series and lends professional-level instruments and bows to young, career-bound classical musicians. Mr. Mendelsohn received his B.A. from UCLA and J.D. from Loyola University School of Law Los Angeles.
How old is Aaron Mendelsohn?
Aaron Mendelsohn is 67, he's been the Independent Director of Vivani Medical Inc since . There are no older and 12 younger executives at Vivani Medical Inc.
What's Aaron Mendelsohn's mailing address?
Aaron's mailing address filed with the SEC is 224 15TH STREET, , SANTA MONICA, CA, 90402.
Insiders trading at Vivani Medical Inc
Over the last 10 years, insiders at Vivani Medical Inc have traded over 9,497,123$ worth of Vivani Medical Inc stock and bought 22,269,890 units worth 31,710,900$ . The most active insiders traders include Alfred E Mann、Gregg Williams、E. Mann Living Trust Incume.... On average, Vivani Medical Inc executives and independent directors trade stock every 31 days with the average trade being worth of 1,432,564$. The most recent stock trade was executed by Gregg Williams on 13 June 2022, trading 3,800 units of EYES stock currently worth 7,600$.
What does Vivani Medical Inc do?
Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in neuromodulation devices for blindness, the Company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. The Company's headquarters are in Los Angeles, California.
What does Vivani Medical Inc's logo look like?
Complete history of Mr. Mendelsohn stock trades at Vivani Medical Inc
Vivani Medical Inc executives and stock owners
Vivani Medical Inc executives and other stock owners filed with the SEC include:
-
Jonathan McGuire,
Director -
Stephen Okland,
Chief Commercial Officer -
Stephen D. Okland Jr.,
Chief Strategy & Bus. Devel. Officer -
Edward Randolph,
Vice President - Manufacturing -
Scott Dunbar,
Acting Chief Exec. Officer -
Dr. Jessy Dana Dorn Ph.D.,
VP of Clinical & Scientific Affairs -
Edward David Randolph,
VP of Operations -
Edward Jonathon Sedo,
Acting Chief Accounting Officer & Principal Financial Officer -
Aaron Mendelsohn,
Independent Director -
Ted Randolph,
Vice President - Operations -
Matthew Pfeffer,
Acting Chief Executive Officer, Director -
Gregg Williams,
Chairman of the Board -
Lisa M. Wilson,
Founder & Pres of In-Site Communications and Investor Relations for Second Sight -
Gunnar Bjorg,
Founder -
Thomas B Miller,
Chief Financial Officer -
E. Mann Living Trust Incume...,
-
Gregoire Cosendai,
VP of European Operations -
William J Phd Link,
Director -
David Murray Jacques,
VP-Research Development -
John T Blake,
Chief Financial Officer -
William Patrick Ryan,
Chief Operating Officer -
Jessy Dana Dorn,
VP-Clin & Scientific Affairs -
John Anthony Moses,
Commercial VP Americas -
Robert J. Greenberg,
Chief Executive Officer -
Alfred E Mann,
Director -
Anne Marie Juliette Ripley,
VP Regulatory Affairs